Sign in
Taking peopleNo phase

A Trial for Minimally Invasive Neurosurgery With AI-assisted Robotic Guidance for Moderate Basal Ganglia Hemorrhage (RAINBOW-MBH)

Key facts

Who runs it
Second Affiliated Hospital, Zhejiang University, School of Medicine
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
330 people, planned
Started
30 Sept 2025
Expected to end
31 Dec 2027
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Minimally invasive basal ganglion hematoma evacuation with Tract-based AI Robot Guiding System
  • Patients will be managed with guideline-based medications
Record updated
8 January 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (16)Hide the full registry criteria

Who can take part

  • Age ≥18 years at randomization
  • Hypertensive basal ganglia hemorrhage confirmed by CT/CTA
  • Hematoma volume 15-30 mL (excluding 30 mL)
  • Functional impairment (aphasia, hemiparesis with strength ≤3, or NIHSS ≥15)
  • CT shows stable hematoma (≥6h interval, change <5 mL)
  • GCS ≥9
  • Surgery feasible within 72h after onset
  • Pre-ICH mRS ≤1
  • Informed consent obtained according to laws and ethics

Who cannot take part

  • Patients with severe concomitant diseases that may interfere with outcome assessment
  • Radiologically diagnosed cerebrovascular abnormalities, as well as ischemic infarction converting to intracerebral hemorrhage, or recent (within 1 year) recurrence of intracerebral hemorrhage
  • Any irreversible coagulopathy disorders or known coagulation system disease; platelet count <100,000; INR >1.4; use of anticoagulants within 7 days prior to this hemorrhage
  • Hematoma involving the thalamus, midbrain, or other areas
  • Signs of impending brain herniation, such as midline shift >1 cm or changes in the ipsilateral pupil
  • Pregnant or possibly pregnant
  • Poor compliance or follow-up difficulties

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Basal ganglia hemorrhage

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

A nationwide, prospective, multicenter randomized controlled clinical trial to evaluate the therapeutic effects of the fiber tract-based artificial intelligence (AI) Robot Guiding System on the perioperative and long-term recovery of patients with moderate-volume basal ganglion hemorrhage.

The 2 groups in the trial

  • Tract-based AI Robot Guiding System GroupTreatment being tested

    Patients will be operated on minimally invasive puncture and aspiration using Tract-based AI Robot guidance System

    Treatment: Minimally invasive basal ganglion hematoma evacuation with Tract-based AI Robot Guiding System

  • Conservative GroupSham treatment, for comparison

    Patients will be managed with guideline-based medications without surgery

    Treatment: Patients will be managed with guideline-based medications

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Multicenter, RAndomlzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With Al-assisted Robotic Guidance for Moderate Basal Ganglia Hemorrhage (RAINBOW-MBH)
Criteria questions
Built from NCT06465719, who can take part
Record updated
8 January 2026